Investor calendar

Publication of standalone quarterly report (SA-Q) for Q3/FY2025 (Q2 of the calendar year 2026)

Beginning of closed period before publication of quarterly results

Publication of standalone interim report (SA-P) for H1/ FY2025 (Q4 of the calendar year 2025 and Q1 of the calendar year 2026)

Beginning of the closed period before the publication of half-year results

Extraordinary Shareholder Meeting

First day of listing of Syn2bio shares on the regulated market of the WSE